Skip to Content

Industrial-Strength Algae

To you, it might be green pond scum. But to some researchers, algae is a vehicle for making key pharmaceutical and industrial compounds. A recent patent could give one company a virtual corner on the biotech algae market. The patent, issued to Martek Biosciences of Columbia, Md., outlines a process to grow non-algal genes in algal cells. The process takes place in a few hours, in contrast to the months it takes to introduce genes into transgenic crop plants like corn or tobacco. The process could also help model the large-scale production of chemicals in crops in fast-growing algae. Martek is working on algal production methods for docosahexaenoic acid, a baby formula ingredient that aids mental development.

Keep Reading

Most Popular

DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.

“This is a profound moment in the history of technology,” says Mustafa Suleyman.

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

Human-plus-AI solutions mitigate security threats

With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure

Next slide, please: A brief history of the corporate presentation

From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.